Market Overview

Sarcoidosis | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest analysis report on drug pipeline
for sarcoidosis.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for sarcoidosis, including a d ...

Technavio has published a new report on the drug development pipeline for sarcoidosis, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Sarcoidosis: Market overview

Sarcoidosis, also known as the Besneir-Boeck-Schaumann disease, is an
auto-aggressive systemic granulomatous disease that primarily affects
the lungs. However, it can affect almost all the organs of the body. It
is a rare disease due to which patches of red and swollen tissue called
granulomas develop in the organs of the body. It usually affects the
lungs and skin. As the disease progresses, small lumps called granulomas
appear in affected tissues. In most of the cases, these granulomas
disappear, either with or without treatment. The disease can appear
suddenly and then disappear. In some cases, it can develop gradually and
produce symptoms that can be seen during a person's lifetime.

According to a senior market research analyst at Technavio, "Researchers
believe that the disease is caused by an abnormal immune response. In a
healthy person, inflammation occurs as the cells of the body's immune
system work together to protect an organ or tissue from intruders."

Sarcoidosis: Segmentation analysis

This pipeline analysis report segments the sarcoidosis market based on
RoA (subcutaneous, oral, inhalation, and intravenous), therapeutic
modality (small molecule, peptide, recombinant enzyme, monoclonal
antibody, and fusion protein), and geographical segmentation (US,
Netherlands, Germany, and Australia). It provides an in-depth analysis
of the prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

Based on therapeutic modality, more than 44% of the molecules that are
being investigated for the treatment of sarcoidosis are small molecule.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!